Monopar Therapeutics
MNPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645469
In the last 90 days, Monopar Therapeutics insiders filed 0 open-market purchases and 3 sales; 95 institutions reported holding it in 13F filings for Q2 2026, worth $576.1M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Monopar Therapeutics as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +17 vs. Q4 2024
- Shares held
- 2.89M
- +307.7K (+11.9%) vs. Q4 2024
- Total value
- $109.4M
- +$52.2M (+91.5%) vs. Q4 2024
- New holders
- 18
- 6 more added
- Sold out
- 1
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 95 | $576.1M |
| Q1 2026 | 82 | $341.5M |
| Q4 2025 | 74 | $360.8M |
| Q3 2025 | 56 | $354.3M |
| Q2 2025 | 43 | $113.3M |
| Q1 2025 | 35 | $109.4M |
| Q4 2024 | 18 | $57.1M |
| Q3 2024 | 6 | $105.9K |
| Q2 2024 | 12 | $310.1K |
| Q1 2024 | 16 | $268.1K |
| Q4 2023 | 14 | $91.7K |
| Q3 2023 | 14 | $182.2K |
| Q2 2023 | 8 | $164.5K |
| Q1 2023 | 11 | $322.9K |
| Q4 2022 | 10 | $471.0K |
| Q3 2022 | 10 | $314.0K |
| Q2 2022 | 13 | $470.6K |
| Q1 2022 | 13 | $519.8K |
| Q4 2021 | 13 | $657.2K |
| Q3 2021 | 9 | $964.4K |
| Q2 2021 | 10 | $1.10M |
| Q1 2021 | 13 | $1.21M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Monopar Therapeutics; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 1,134,406 | $45.6M | 0.02% | +87,507+8.4% | Added |
| Adage Capital Partners GP, L.L.C. | 599,195 | $21.8M | 0.04% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 511,207 | $18.6M | 0.31% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 168,160 | $6.12M | 0.02% | +268+0.2% | Added |
| ADAR1 Capital Management, LLC | 100,774 | $3.67M | 0.71% | −29,263−22.5% | Reduced |
| Affinity Asset Advisors, LLC | 62,000 | $2.26M | 0.35% | +62,000 | New |
| Millennium Management LLC | 60,367 | $2.20M | 0.00% | +60,367 | New |
| Vanguard Group Inc | 55,234 | $2.01M | 0.00% | −1,275−2.3% | Reduced |
| Geode Capital Management, LLC | 48,540 | $1.77M | 0.00% | +9,944+25.8% | Added |
| Marshall Wace, LLP | 25,988 | $946.2K | 0.00% | +25,988 | New |
| Goldman Sachs Group Inc | 18,480 | $672.9K | 0.00% | +18,480 | New |
| State Street Corp | 15,814 | $575.8K | 0.00% | +15,814 | New |
| BlackRock, Inc. | 14,464 | $526.6K | 0.00% | +6,363+78.5% | Added |
| Jane Street Group, LLC | 10,357 | $377.1K | 0.00% | +10,357 | New |
| Northern Trust Corp | 9,161 | $333.6K | 0.00% | +9,161 | New |
| Omers Administration Corp | 9,000 | $327.7K | 0.00% | +9,000 | New |
| HRT Financial LP | 8,228 | $299.0K | 0.00% | +8,228 | New |
| UBS Group AG | 8,121 | $295.7K | 0.00% | +1,698+26.4% | Added |
| Balyasny Asset Management LLC | 6,141 | $223.6K | 0.00% | +6,141 | New |
| Ikarian Capital, LLC | 5,908 | $215.1K | 0.07% | 00.0% | Unchanged |
| Gerber, LLC | 5,601 | $203.9K | 0.17% | +5,601 | New |
| Bank of America Corp | 2,478 | $90.2K | 0.00% | +2,450+8,750.0% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 1,761 | $64.1K | 0.02% | +1,761 | New |
| Morgan Stanley | 1,424 | $51.8K | 0.00% | −2,377−62.5% | Reduced |
| Quest Partners LLC | 1,215 | $44.2K | 0.00% | +1,215 | New |
| GWM Advisors LLC | 600 | $21.8K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 303 | $11.0K | 0.00% | −393−56.5% | Reduced |
| Wells Fargo & Company | 250 | $9.10K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 225 | $8.19K | 0.00% | +225 | New |
| Point72 (DIFC) Ltd | 196 | $7.13K | 0.00% | +196 | New |
| Royal Bank of Canada | 205 | $7.00K | 0.00% | +205 | New |
| Allworth Financial LP | 100 | $4.46K | 0.00% | +100 | New |
| JPMorgan Chase & Co | 100 | $3.64K | 0.00% | −1,937−95.1% | Reduced |
| Federation des caisses Desjardins du Quebec | 16 | $583 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 12 | $437 | 0.00% | +12 | New |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −100−100.0% | Sold out |